Shirzad Gholami
Overview
Explore the profile of Shirzad Gholami including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
349
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sadeghi M, Hosseini S, Sarvi S, Ebrahimnejad P, Asgarian Omran H, Zare Z, et al.
Iran J Pharm Res
. 2025 Jan;
23(1):e150424.
PMID: 39830651
Background: transmission can occur during pregnancy if the mother contracts the infection for the first time. Treatment strategies include the use of antimicrobial medications and providing supportive care. Spiramycin is...
2.
Tork M, Sarvi S, Asgarian-Omran H, Sadeghi M, Basirpour B, Hatami Nejad M, et al.
Exp Parasitol
. 2024 Dec;
268():108883.
PMID: 39722312
Toxoplasmosis which is caused by T. gondii, is common among humans and animals. T. gondii is a threat to the fetus and individuals with immune disorders, especially patients with acquired...
3.
Sadeghi M, Hosseini S, Sarvi S, Ebrahimnejad P, Asgaryan Omran H, Zare Z, et al.
Trop Med Health
. 2024 Oct;
52(1):71.
PMID: 39407341
No abstract available.
4.
Sadeghi M, Hosseini S, Sarvi S, Ebrahimnejad P, Asgaryan Omran H, Zare Z, et al.
Trop Med Health
. 2024 Sep;
52(1):64.
PMID: 39343977
Background: Congenital toxoplasmosis occurs when a pregnant woman becomes infected with Toxoplasma gondii (T. gondii) for the first time. Treatment typically involves antimicrobial medications, with spiramycin commonly used to prevent...
5.
Anvari D, Gholami S, Spotin A, Hosseini S, Daryani A, Sarvi S, et al.
Iran J Parasitol
. 2024 Jul;
19(2):140-152.
PMID: 39011532
Background: Current study was designed to provide a better insight into the circulating genotypes, genetic diversity, and population structure of spp. between southeast of Iran and Pakistan Methods: From Jun...
6.
Gholami Koohestan M, Saberi R, Daryani A, Sarvi S, Sharifdini M, Anvari D, et al.
Parasite Epidemiol Control
. 2024 May;
25:e00353.
PMID: 38699631
Cystic echinococcosis (CE) is a significant health problem in both human and veterinary medicine. It is caused by the tapeworm The objective of this study was to investigate molecular diversity...
7.
Habibi B, Gholami S, Bagheri A, Fakhar M, Torabi M, Tabaripour R, et al.
Mol Biol Rep
. 2024 Mar;
51(1):452.
PMID: 38536533
Background: The diagnostic tool for identifying cystic echinococcosis (CE) patients at an early stage is currently lacking. However, circulatory cell-free DNA (cfDNA) has shown potential as a biomarker for parasitic...
8.
Hataminejad M, Anvari D, Khaleghi N, Nayeri T, Shirazinia R, Shariatzadeh S, et al.
Vet Anim Sci
. 2024 Mar;
24:100345.
PMID: 38516388
The larval stages of () are what cause the zoonotic disease known as alveolar echinococcosis (AE). Identifying the antigens that trigger immune responses during infection is extremely important for the...
9.
Darzi F, Asgarian-Omran H, Sarvi S, Valadan R, Hataminejad M, Mayahi S, et al.
Infect Disord Drug Targets
. 2024 Feb;
24(7):e200224227165.
PMID: 38415436
Introduction: Cystic echinococcosis (CE) is a zoonotic parasitic disease caused by the metacestode of Echinococcus granulosus. CE is a health problem in Middle Eastern countries, such as Iran. The purpose...
10.
Nasibi S, Mojarrab S, Lashkarizadeh M, Shafiei M, Dezaki E, Mahmoudvand H, et al.
Arch Iran Med
. 2024 Feb;
26(7):358-364.
PMID: 38301093
Background: Cystic echinococcosis (CE) or hydatid disease is a global public health concern which imposes considerable economic costs on the communities in endemic regions. CE surveillance data are not adequately...